The Sky Shop For Hope
Pet collar & leash
Pet collar & leash
Couldn't load pickup availability
• Durable 100% polyester webbing
• 92% polyester, 8% spandex collar and leash handle inside
• Black 100% polyester sponge collar and handle padding
• Metal snap hook and D-ring for the leash
• Black plastic main buckle, adjustable buckle, and strap holder for the collar
• Leash length: 6 ft. (1.83 m)
• Leash and collar width: 1″ (2.54 cm)
• 3 collar sizes available: S 11.8″–17.8″ (30–45 cm), M 13.5″–20.5″ (35–52 cm), L 14.8″–23.8″ (38–60 cm)
• Adjustable collar length
• Blank product sourced from China
Hand wash with mild detergent or machine wash on a gentle cycle in a mesh bag. Air dry.
Share




Recent News
View all-
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
Phase 1/2 Trial Launches for Innovative Pancrea...
UCSF researchers begin testing novel TCR-T cell therapy targeting KRAS mutations in advanced pancreatic cancer. A new clinical trial at UCSF has opened to test a first-of-its-kind immunotherapy for advanced...
-
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
FDA Approves NALIRIFOX as First-Line Treatment ...
New frontline treatment offers hope with improved survival outcomes for advanced PDAC patients The U.S. Food and Drug Administration (FDA) has officially approved NALIRIFOX, a new frontline therapy for patients with metastatic...
-
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...
Immunotherapy for Pancreatic Ductal Adenocarcin...
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a 5-year survival rate under 10%. Standard treatments like surgery and chemotherapy often fail because the cancer usually comes...